{
    "clinical_study": {
        "@rank": "6774", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a\n      specific panel of red cell characteristics in patients with sickle cell syndromes."
        }, 
        "brief_title": "Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes", 
        "condition": "Sickle Cell Anemia", 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Anemia, Sickle Cell"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients receive oral hydroxyurea either once or twice daily plus oral clotrimazole twice\n      daily after meals for 6 months.  Patients are assessed at 3 and 6 months during treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Sickle cell syndromes characterized by vaso-occlusive crises\n        sufficiently severe to require prophylactic therapy Three or more crises per year\n        sufficiently severe to require hospitalization Stable dose of hydroxyurea for at least 4\n        months required --Prior/Concurrent Therapy-- No treatment with any other antisickling\n        agents within the past 4 months Biologic therapy: No transfusion within 90 days No\n        concurrent chronic transfusions allowed (defined as more than one transfusion per month\n        for 2 or more months) Chemotherapy: See Disease Characteristics Endocrine therapy: Not\n        specified Radiotherapy: Not specified Surgery: Not specified Other: No chronic medications\n        that alter neurologic, renal, or hepatic functions\n\n          -  Patient Characteristics--            Performance status: Karnofsky 70-100%\n             Hematopoietic: WBC within normal limits Platelet count within normal limits Hepatic:\n             No history of chronic liver disease Bilirubin less than 2 times normal SGOT and SGPT\n             less than 2.5 times normal No severe hepatic damage Renal: Creatinine within normal\n             limits No severe renal damage Neurologic: No severe neurologic impairment No recent\n             or progressive neurologic impairment Other: Not pregnant Fertile patients must use\n             effective contraception No allergies to hydroxyurea or clotrimazole"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004404", 
            "org_study_id": "199/13288", 
            "secondary_id": [
                "CH-B-97-052", 
                "CH-B-FDR001022"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "clotrimazole", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "hydroxyurea", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clotrimazole", 
                "Miconazole", 
                "Hydroxyurea"
            ]
        }, 
        "keyword": [
            "genetic diseases and dysmorphic syndromes", 
            "hematologic disorders", 
            "rare disease", 
            "sickle cell anemia"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "contact": {
                    "last_name": "Kenneth R Bridges", 
                    "phone": "617-432-1000"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham and Women's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Carlo Brugnara", 
                    "phone": "617-355-6347"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Children's Hospital - Boston"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Children's Hospital Boston", 
            "last_name": "Carlo Brugnara", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004404"
        }, 
        "source": "FDA Office of Orphan Products Development", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Hospital Boston", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "FDA Office of Orphan Products Development", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "April 1997", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 1998"
    }, 
    "geocoordinates": {
        "Brigham and Women's Hospital": "42.358 -71.06", 
        "Children's Hospital - Boston": "42.358 -71.06"
    }
}